The Laura Crandall Brown Ovarian Cancer Foundation of Birmingham has awarded a $50,000 grant to support the work of Dr. Rodney Rocconi at the Mitchell Cancer Institute who is teaming with Swift Biotechnology to develop a screen to ensure early detection of ovarian cancer.
Foundation Awards Grant to Mitchell Cancer Institute
The Laura Crandall Brown Ovarian Cancer Foundation of Birmingham has awarded a $50,000 grant to support the work of Dr. Rodney Rocconi at the Mitchell Cancer Institute (“MCI”) at the University of South Alabama in Mobile.
Currently, there is no accurate and effective cancer screening tool for ovarian cancer. Because there are few, if any, symptoms in the early stages, ovarian cancer often goes undetected until it has spread. Many women die from ovarian cancer for one simple reason: they are diagnosed too late to be saved. When diagnosed in later stages after the disease has spread, 3 out of 4 women die. When diagnosed early virtually every woman survives the disease. In addition, early detection means that costly and debilitating radiation and chemotherapy treatment are avoided.
Dr. Rodney Rocconi, along with fellow inventors Dr. Michael Finan and Dr. Louis Pannell at MCI, are working with Swift Biotechnology to develop a screen to ensure early detection. Having licensed the technology from USA, Swift and MCI are working as a team to develop the technology. Swift’s development plan for this technology was one of the winners in the 2010 Alabama Launchpad business competition. Swift’s President and CEO, Dr. Michael Chambers, commented, “the Laura Crandall Brown Foundation (www.thinkoflaura.org) is passionately committed to saving women from ovarian cancer. We are honored to work with MCI and help support the work of Dr. Rocconi and his fellow inventors at MCI to help develop a screen to save thousands of lives.”